Tumor lysate-cloaked CuMOF-sorafenib nanoassembler: A synergistic cuproptosis-ferroptosis nanoweapon against tumors
Year: 2025
Type: article
Abstract: studies demonstrate the efficient tumor accumulation, growth suppression, and metastasis inhibition of CMSP. By integrating biomimetic targeting, oxidative stress amplification, and dual-pathway synergy, CMSP presents a promising strategy to advance the development of personalized antitumor nanomedicines.
Source: Materials Today Bio
Institutions: Chongqing University, Shenzhen University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,400
OpenAlex ID: W4417048536
